Documents

Files(15)

Name Size/Type Description Date
AIDA consent 112KB PDF AIDA consent 21 Apr 2020
Arsenic with Tretinoin consent 112KB PDF Arsenic with Tretinoin consent 21 Apr 2020
Azacitidine + Venetoclax consent 116KB PDF Azacitidine and Venetoclax consent 05 Aug 2024
Azacitidine consent 112KB PDF Azacitidine consent 21 Apr 2020
Cytarabine subcut consent 111KB PDF Cytarabine subcut consent 21 Apr 2020
DA consent 112KB PDF DA consent 21 Apr 2020
FLAG+-Ida consent 113KB PDF FLAG+-Ida consent 21 Apr 2020
Gilteritinib consent 111KB PDF Gilteritinib consent 31 Jul 2020
High dose Cytarabine consent 112KB PDF High dose Cytarabine consent 21 Apr 2020
Lenalidomide for MDS consent 111KB PDF Lenalidomide consent 05 Jun 2020
MIDAC consent 112KB PDF MIDAC consent 21 Apr 2020
Midostaurin consent 111KB PDF Midostaurin consent 21 Apr 2020
Mylotarg consent 113KB PDF Mylotarg consent 21 Apr 2020
Tretinoin consent 110KB PDF Tretinoin consent 21 Apr 2020
Vyxeos consent 114KB PDF Vyxeos consent 21 Apr 2020

Chemotherapy Consent Forms for Haematology

All consent forms on this website are for the use of St Luke’s Cancer Alliance staff in respect of St Luke’s Cancer Alliance patients only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for the use of any information that may be set out on the website. You assume full responsibility for the use of the information.  You may wish to take your own legal advice before using any of the consent forms.

Please note that the consent forms below are not tumour-specific; one consent form may be used to consent patients for more than one St Luke’s Alliance chemotherapy protocol which uses the same combination of chemotherapy.

These consent forms should act as an aide-memoire to health professionals and patients, by providing a check-list of the kind of information which patients should be offered, and by enabling the patient to have a written record of the main points discussed.

The relevant Macmillan/CRUK leaflet(s) should also be provided to each patient before consent. In no way, however, should written information given to the patient be regarded as a substitute for face-to-face discussions with the patient.